Counting the Cost of Daptomycin Versus Vancomycin in Hospitalized Patients: A Cost Minimization Analysis.

Authors :: Wagner, Jamie L
Jones, Bruce M
Stover, Kayla R
Cleary, John D
Bland, Christopher M
Schipper, Katie E
Chastain, Daniel B
Barber, Katie E
Source :: Open Forum Infectious Diseases. May2024, Vol. 11 Issue 5, p1-4. 4p.
Publication Year :: 2024
Abstract: Daptomycin use for gram-positive infections has increased. This cost minimization analysis aimed to determine cost and/or time savings of daptomycin over vancomycin. The estimated hospital cost savings was US$166.41 per patient, and pharmacist time saved of almost 20 minutes per patient. Daptomycin has the potential to save both time and money. [ABSTRACT FROM AUTHOR]

Subjects :: *COST analysis
*DAPTOMYCIN
*HOSPITAL patients
*VANCOMYCIN
*HOSPITAL costs

Full Text Access

Tools